Kamada (KMDA) Capital Expenditures (2013 - 2026)
Kamada (KMDA) reported Capital Expenditures of -$973000.0 for Q1 2026, up 33.72% on a YoY basis from -$727643.4 in Q1 2025, and up 64.94% quarter-over-quarter from -$2.8 million in Q4 2025.
Kamada (KMDA) Capital Expenditures (2013 - 2026) Analysis & Trends
Kamada has reported Capital Expenditures for 14 years, with the latest figure at -$973000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 33.72% year-over-year to -$973000.0; the trailing twelve-month figure through Mar 2026 stood at -$9.4 million (down 154.24% YoY), and the FY2025 full-year result was -$9.8 million, down 191.68% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$973000.0, up from -$2.8 million in the prior quarter.
- The five-year high for Capital Expenditures was $2.9 million in Q4 2024, with the low at -$3.6 million in Q3 2025.
- Historically, Capital Expenditures has averaged -$1.0 million across 5 years, with a median of -$1.0 million in 2023.
- Annual changes were most pronounced in 2023 — Capital Expenditures surged 302.05% — and 2024, when it tumbled 240007.43%.
- Kamada's Capital Expenditures stood at -$977000.0 in 2022, then soared by 302.05% to $2.0 million in 2023, then surged by 48.13% to $2.9 million in 2024, then slumped by 194.9% to -$2.8 million in 2025, then jumped by 64.94% to -$973000.0 in 2026.
- The last three Capital Expenditures figures came in at -$973000.0 (Q1 2026), -$2.8 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Kamada | 504.70 | -73.15 Mn | 19.12 Mn | -973,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -973,000.00 |
| Mar 31, 2026 | -973,000.00 |
| Dec 31, 2025 | -2.78 Mn |
| Dec 31, 2025 | -2.78 Mn |
| Sep 30, 2025 | -3.59 Mn |
| Sep 30, 2025 | -3.59 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Jun 30, 2025 | -2.01 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Sep 30, 2024 | -2.12 Mn |
| Jun 30, 2024 | -3.01 Mn |
| Jun 30, 2024 | -3.01 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Mar 31, 2024 | -2.68 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Dec 31, 2023 | 1.97 Mn |